Cytokine and complement levels in patients undergoing cardiopulmonary bypass
- 1 December 1993
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 106 (6) , 1008-1016
- https://doi.org/10.1016/s0022-5223(19)33971-6
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Recombinant human interleukin‐6 (IL‐6/BSF‐2/HSF) regulates the synthesis of acute phase proteins in human hepatocytesPublished by Wiley ,2001
- Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenationThe Annals of Thoracic Surgery, 1992
- C5a-mediated release of interleukin 6 by human monocytesClinical Immunology and Immunopathology, 1990
- Complement activation and lung permeability during cardiopulmonary bypassThe Annals of Thoracic Surgery, 1990
- Reduction of complement activation during bypass by prime manipulationThe Annals of Thoracic Surgery, 1990
- Complement Activation in Cardiopulmonary Bypass, with Special Reference to Anaphylatoxin Production in Membrane and Bubble OxygenatorsThe Annals of Thoracic Surgery, 1988
- Deposition of Terminal C5b–9 Complement Complexes on Erythrocytes and Leukocytes during Cardiopulmonary BypassNew England Journal of Medicine, 1988
- Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor.The Journal of Experimental Medicine, 1987
- Effects of Protamine Administration after Cardiopulmonary Bypass on Complement, Blood Elements, and the Hemodynamic StateThe Annals of Thoracic Surgery, 1986
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981